{Reference Type}: Editorial
{Title}: Antibody-drug conjugate development: opening windows for EGFR-mutant EGFR tyrosine kinase inhibitor-resistant non-small cell lung cancers?
{Author}: Hida T;
{Journal}: Transl Lung Cancer Res
{Volume}: 13
{Issue}: 4
{Year}: 2024 Apr 29
{Factor}: 4.726
{DOI}: 10.21037/tlcr-24-100